WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2013059469) GENETIC ALTERATIONS AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF TYPE I DIABETES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2013/059469    International Application No.:    PCT/US2012/060825
Publication Date: 25.04.2013 International Filing Date: 18.10.2012
IPC:
C12Q 1/68 (2006.01), A61P 3/10 (2006.01), A61P 7/12 (2006.01)
Applicants: THE CHILDREN'S HOSPITAL OF PHILADELPHIA [US/US]; 34th Street & Civic Center Boulevard Philadelphia, PA 19104 (US)
Inventors: BRADFIELD, Jonathan; (US).
GRANT, Struan, F.a.; (US).
HAKONARSON, Hakon; (US)
Agent: RIGAUT, Kathleen, D.; Dann, Dorfman, Herrell & Skillman 1601 Market Street, Suite 2400 Philadelphia, PA 19103-2307 (US)
Priority Data:
61/548,457 18.10.2011 US
Title (EN) GENETIC ALTERATIONS AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF TYPE I DIABETES
(FR) MODIFICATIONS GÉNÉTIQUES ET LEURS MÉTHODES D'UTILISATION EN VUE DU DIAGNOSTIC ET DU TRAITEMENT DU DIABÈTE DE TYPE I
Abstract: front page image
(EN)Compositions and methods for the diagnosis and treatment of T1D are disclosed. More specifically, the invention provides gene targets containing single nucleotide polymorphisms associated with this disease. Methods and kits for using the sequences so identified for diagnostic and therapeutic purposes are also provided.
(FR)La présente invention concerne des compositions et des méthodes de diagnostic et de traitement du diabète de type I. L'invention concerne, plus précisément, des gènes cibles contenant des polymorphismes mononucléotidiques associés à ladite maladie. L'invention concerne également des méthodes et des nécessaires permettant d'utiliser les séquences ainsi identifiées à des fins diagnostiques et thérapeutiques.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)